| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of the rates of clot lysis in a plasma milieu induced by tissue plasminogen activator (t-PA) and rec-pro-urokinase: Evidence that t-PA has a more restricted mode of action
|
Pannell, R.
|
|
1992
|
|
1 |
p. 1-5
5 p.
|
artikel
|
| 2 |
Activation of the intrinsic fibrinolytic pathway with normal extrinsic responses in a patient undergoing gastric surgery
|
Grant, P.J.
|
|
1990
|
|
1 |
p. 41-43
3 p.
|
artikel
|
| 3 |
An investigation of methods to prevent fibrinogen degradation during processing of plasma samples containing the fibrinolytic agents, APSAC and t-PA
|
Fears, R.
|
|
1989
|
|
1 |
p. 45-49
5 p.
|
artikel
|
| 4 |
Announcement
|
|
|
1990
|
|
1 |
p. 67-
1 p.
|
artikel
|
| 5 |
A novel serine protease inhibitor from the Australian brown snake, Pseudonaja textilis textilis: Inhibition kinetics
|
Willmott, N.
|
|
1995
|
|
1 |
p. 1-8
8 p.
|
artikel
|
| 6 |
A recombinant pro-urokinase derived mutant missing the growth factor-like domain does not bind to its receptor
|
Robbiati, F.
|
|
1990
|
|
1 |
p. 53-60
8 p.
|
artikel
|
| 7 |
A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasma
|
Gram, J.
|
|
1987
|
|
1 |
p. 33-37
5 p.
|
artikel
|
| 8 |
Association between systemic generation of plasmin and activation of the factor XII-dependent fibrinolytic proactivator system in coronary thrombolysis
|
Munkvad, S.
|
|
1992
|
|
1 |
p. 57-62
6 p.
|
artikel
|
| 9 |
A study of the transient increase in blood fibrinolytic activity during haemodialysis
|
Jespersen, J.
|
|
1987
|
|
1 |
p. 51-55
5 p.
|
artikel
|
| 10 |
Biodisposition and catabolism of tissue-type plasminogen activator in rats and rabbits
|
Bakhit, C.
|
|
1988
|
|
1 |
p. 31-36
6 p.
|
artikel
|
| 11 |
Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise or fat modified diet Randomized clinical trial in middle-aged men
|
Rankinen, T.
|
|
1994
|
|
1 |
p. 48-53
6 p.
|
artikel
|
| 12 |
Blood group serology
|
Voak, D.
|
|
1989
|
|
1 |
p. 56-
1 p.
|
artikel
|
| 13 |
Blood transfusion methods in hematology
|
Boulton, F.E.
|
|
1989
|
|
1 |
p. 55-
1 p.
|
artikel
|
| 14 |
Bylaws of the international society for fibrinolysis and thrombolysis
|
|
|
1993
|
|
1 |
p. i-iii
nvt p.
|
artikel
|
| 15 |
Can physical activity explain the differences in insulin levels and fibrinolytic activity between young indo-origin and European relatives of patients with coronary artery disease?
|
Shaukat, N.
|
|
1995
|
|
1 |
p. 55-63
9 p.
|
artikel
|
| 16 |
Characterisation of a chemical conjugate between a low molecular weight form of recombinant single chain urokinase-type plasminogen activator (comprising Leu144 through Leu411) and F(ab′)2-fragments of a fibrin D-dimer-specific monoclonal antibody
|
Dewerchin, M.
|
|
1990
|
|
1 |
p. 11-18
8 p.
|
artikel
|
| 17 |
Characterisation of conjugates of thrombin-treated single chain urokinase-type plasminogen activator with a monoclonal antibody specific for crosslinked fibrin
|
Dewerchin, M.
|
|
1990
|
|
1 |
p. 19-26
8 p.
|
artikel
|
| 18 |
Characterization of the oligosaccharide structures on a recombinant tissue-type plasminogen activator analog synthesized in chinese hamster ovary cells
|
Aeed, P.A.
|
|
1994
|
|
1 |
p. 31-41
11 p.
|
artikel
|
| 19 |
Circadian fluctuations in plasma levels of tissue plasminogen activator antigen and plasminogen activator inhibitor activity
|
Huber, K.
|
|
1989
|
|
1 |
p. 41-43
3 p.
|
artikel
|
| 20 |
Circadian variations of extrinsic fibrinolytic components in blood from eskimos
|
Johansen, L.G.
|
|
1990
|
|
1 |
p. 35-39
5 p.
|
artikel
|
| 21 |
Circulatory metabolism of recombinant tissue-type plasminogen activator in monkeys and rabbits
|
Mohler, M.A.
|
|
1988
|
|
1 |
p. 17-23
7 p.
|
artikel
|
| 22 |
Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro
|
Lijnen, H.R.
|
|
1992
|
|
1 |
p. 33-37
5 p.
|
artikel
|
| 23 |
Comparison of oral stanozolol with low dose heparin in prevention of deep venous thrombosis in high risk patients after elective major abdominal surgery
|
Sue-Ling, H.M.
|
|
1988
|
|
1 |
p. 37-41
5 p.
|
artikel
|
| 24 |
Comparison of the effects of unfractionated heparin, low molecular weight heparin and hirudin (revasc™) on the fibrinolytic potential of cultured human umbilical vein endothelial cells
|
Chordá, C.
|
|
1996
|
|
1 |
p. 43-48
6 p.
|
artikel
|
| 25 |
Comparison of the immunohistochemical localisation of urokinase in normal and cancerous human colon tissue
|
Kohga, S.
|
|
1989
|
|
1 |
p. 17-22
6 p.
|
artikel
|
| 26 |
Congenital abnormal plasminogen chicago IV: A dysplasminogenemia with 50% potential active sites with active centre, charge mutations and kinetics of activation defects
|
Kozlowski, K.A.
|
|
1995
|
|
1 |
p. 29-40
12 p.
|
artikel
|
| 27 |
CT-stereotactic evacuation and fibrinolysis of hypertensive intracranial haematoma
|
Mohadjer, M.
|
|
1988
|
|
1 |
p. 43-48
6 p.
|
artikel
|
| 28 |
Determinants of clearance of tissue-type plasminogen activator (t-PA) from the circulation
|
Devries, S.R.
|
|
1987
|
|
1 |
p. 17-21
5 p.
|
artikel
|
| 29 |
Differential detection of single chain urokinase-type plasminogen activator and two chain urokinase-type plasminogen activator in human and monkey plasma
|
Molinari, A.
|
|
1992
|
|
1 |
p. 17-26
10 p.
|
artikel
|
| 30 |
Different induction pathways for urokinase (u-PA) in A431 cells by EGF and by the phorbol ester, TPA
|
Kessler, T.L.
|
|
1993
|
|
1 |
p. 31-40
10 p.
|
artikel
|
| 31 |
Editorial
|
Davidson, John F.
|
|
1987
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 32 |
Editorial Board
|
|
|
1996
|
|
1 |
p. CO2-
1 p.
|
artikel
|
| 33 |
Editorial Board
|
|
|
1995
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 34 |
Editorial Board
|
|
|
1994
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 35 |
Editorial Board
|
|
|
1987
|
|
1 |
p. IFC-
1 p.
|
artikel
|
| 36 |
Editorial Board
|
|
|
1989
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 37 |
Editorial Board
|
|
|
1992
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 38 |
Editorial Board
|
|
|
1993
|
|
1 |
p. II-
1 p.
|
artikel
|
| 39 |
Editorial Board
|
|
|
1991
|
|
1 |
p. vi-
1 p.
|
artikel
|
| 40 |
Editorial Board
|
|
|
1990
|
|
1 |
p. iv-
1 p.
|
artikel
|
| 41 |
Editorial Board
|
|
|
1988
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 42 |
Effect of activated protein c on the fibrinolytic components released by cultured bovine aortic endothelial cells
|
Sakata, Y.
|
|
1988
|
|
1 |
p. 7-15
9 p.
|
artikel
|
| 43 |
Effect of aspirin on plasminogen activator release in perfused rat hindlegs
|
Iacoviello, L.
|
|
1992
|
|
1 |
p. 63-68
6 p.
|
artikel
|
| 44 |
Effect of fibrinogen-clotting enzymes on secretion of plasminogen activators from cultured human endothelial cells
|
Soszka, T.
|
|
1988
|
|
1 |
p. 49-57
9 p.
|
artikel
|
| 45 |
Effect of metoprolol on fibrinolytic activity in hypertensive patients with high plasminogen activator inhibitor activity
|
de Vries, R.A.
|
|
1994
|
|
1 |
p. 61-64
4 p.
|
artikel
|
| 46 |
Effect of plasminogen and tissue-type plasminogen activator on fibrin gel structure
|
Petersen, L.C.
|
|
1991
|
|
1 |
p. 51-59
9 p.
|
artikel
|
| 47 |
Effect of ridogrel, a combined thromboxane A2 synthase inhibitor/ prostaglandin endoperoxide receptor antagonist, on the lysis of platelet-rich coronary arterial thrombi with recombinant tissue-type plasminogen activator in a canine model
|
Collen, D.
|
|
1992
|
|
1 |
p. 7-15
9 p.
|
artikel
|
| 48 |
Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis. A randomised controlled study
|
Sørensen, J.D.
|
|
1994
|
|
1 |
p. 54-60
7 p.
|
artikel
|
| 49 |
Fibrinolysis and oral anticoagulation
|
van Wersch, J.W.J.
|
|
1993
|
|
1 |
p. 47-49
3 p.
|
artikel
|
| 50 |
Fibrinolytic properties of single chain urokinase-type plasminogen activator (Pro-urokinase)
|
de Munk, G.A.W.
|
|
1990
|
|
1 |
p. 1-9
9 p.
|
artikel
|
| 51 |
Fibrinolytic status of the normal human fetus: association with undetectable levels of histidin-rich glycoprotein and lipoprotein(a)
|
Reverdiau-Moalic, P.
|
|
1996
|
|
1 |
p. 55-57
3 p.
|
artikel
|
| 52 |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) increases plasma fibrinolytic activity in vivo
|
Yong, K.L.
|
|
1994
|
|
1 |
p. 42-47
6 p.
|
artikel
|
| 53 |
Haemostasis and thrombosis
|
Lowe, G.D.O.
|
|
1988
|
|
1 |
p. 59-
1 p.
|
artikel
|
| 54 |
Human hepatocytes express the gene for type 1 plasminogen activator-inhibitor (PAI-1) in vivo
|
Thornton, A.J.
|
|
1995
|
|
1 |
p. 9-15
7 p.
|
artikel
|
| 55 |
Hyperfibrinolysis but not hypercoagulability after a new ascites-apheresis procedure in liver cirrhosis patients with refractory ascites
|
Legnani, C.
|
|
1996
|
|
1 |
p. 15-20
6 p.
|
artikel
|
| 56 |
Increased fibrin formation in blood in women above the age of 30 who are both oral contraceptive users and smokers
|
Jespersen, J.
|
|
1996
|
|
1 |
p. 9-13
5 p.
|
artikel
|
| 57 |
Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled study
|
Munkvad, S.
|
|
1992
|
|
1 |
p. 45-50
6 p.
|
artikel
|
| 58 |
Influence of an ultramarathon race at moderate altitude on coagulation and fibrinolysis
|
Schobersberger, W.
|
|
1996
|
|
1 |
p. 37-42
6 p.
|
artikel
|
| 59 |
Influence of factor XIII-mediated crosslinking on fibrinolysis by leukocyte elastase
|
Carmassi, F.
|
|
1990
|
|
1 |
p. 45-51
7 p.
|
artikel
|
| 60 |
Influence of heparin and various glycosaminoglycans on activation of single chain urokinase-type plasminogen activator (scu-PA) by plasmin
|
Watahiki, Y.
|
|
1989
|
|
1 |
p. 31-35
5 p.
|
artikel
|
| 61 |
Interaction of tissue-type plasminogen activator with fibronectin and fibronectin fragments
|
Marchina, E.
|
|
1993
|
|
1 |
p. 51-57
7 p.
|
artikel
|
| 62 |
International Committee for Fibrinolysis—Kabi Prize Lecture 1986
|
Müllertz, S.
|
|
1987
|
|
1 |
p. 3-12
10 p.
|
artikel
|
| 63 |
In vivo clearance of tissue plasminogen activator: The complex role of sites of glycosylation and level of sialylation
|
Cole, E.S.
|
|
1993
|
|
1 |
p. 15-22
8 p.
|
artikel
|
| 64 |
Kinetics of transperitoneal tissue-type plasminogen activator absorption
|
Holmdahl, L.
|
|
1996
|
|
1 |
p. 1-7
7 p.
|
artikel
|
| 65 |
Localization of epitopes recognized by monoclonal antibodies on tissue-type and urokinase-type plasminogen activators using recombinant hybrid enzymes
|
Asselbergs, F.A.M.
|
|
1993
|
|
1 |
p. 1-14
14 p.
|
artikel
|
| 66 |
Maywood II: A congenitally abnormal plasminogen with defective lysine-binding sites associated with stroke in a 16-year-old male
|
Kozlowski, K.A.
|
|
1995
|
|
1 |
p. 17-27
11 p.
|
artikel
|
| 67 |
Mice release less tissue-type plasminogen activator (t-PA) and have more active clot stabilization by FXIII compared to rats which might explain their low rate of blood clot lysis
|
van Giezen, J.J.J.
|
|
1994
|
|
1 |
p. 1-8
8 p.
|
artikel
|
| 68 |
Murine monoclonal antibodies against active site epitopes on human endothelial plasminogen activator inhibitor (PAI-1)
|
MacGregor, I.R.
|
|
1990
|
|
1 |
p. 27-34
8 p.
|
artikel
|
| 69 |
Notices
|
|
|
1988
|
|
1 |
p. 60-
1 p.
|
artikel
|
| 70 |
Notices
|
|
|
1994
|
|
1 |
p. 65-66
2 p.
|
artikel
|
| 71 |
Notices
|
|
|
1989
|
|
1 |
p. 57-
1 p.
|
artikel
|
| 72 |
Notices
|
|
|
1987
|
|
1 |
p. 65-
1 p.
|
artikel
|
| 73 |
Obituary Professor Kurt Nikolai von Kaulla MD 1912–1986
|
J.F.D.,
|
|
1987
|
|
1 |
p. 63-
1 p.
|
artikel
|
| 74 |
Occurrence of a specific plasminogen activator inhibitor of placental type, PAI-2, in men and non-pregnant women
|
Lecander, I.
|
|
1989
|
|
1 |
p. 27-30
4 p.
|
artikel
|
| 75 |
One chain variants of tissue plasminogen activator have increased susceptibility to inactivation by plasmin
|
Higgins, D.L.
|
|
1991
|
|
1 |
p. 43-49
7 p.
|
artikel
|
| 76 |
Pharmacokinetics of the novel recombinant plasminogen activator BM 06.022 in rats, dogs, and non-human primates
|
Martin, U.
|
|
1992
|
|
1 |
p. 39-43
5 p.
|
artikel
|
| 77 |
Plasma assays for derivatives of fibrin and of fibrinogen, based on monoclonal antibodies
|
Nieuwenhuizen, W.
|
|
1988
|
|
1 |
p. 1-5
5 p.
|
artikel
|
| 78 |
Plasminogen activator activity and composition in human colorectal carcinomas
|
de Bruin, P.A.F.
|
|
1987
|
|
1 |
p. 57-62
6 p.
|
artikel
|
| 79 |
Plasminogen activator inhibitor induced by lipopolysaccharide injection in the rat Zymographic analysis
|
Dosne, A.M.
|
|
1987
|
|
1 |
p. 45-49
5 p.
|
artikel
|
| 80 |
Plasminogen activators in bovine milk during mastitis, an inflammatory disease
|
Heegaard, C.W.
|
|
1994
|
|
1 |
p. 22-30
9 p.
|
artikel
|
| 81 |
Potentiating effects of anticoagulants and antiplatelet agents on streptokinase-induced thrombolysis in the rabbit
|
Bernat, A.
|
|
1993
|
|
1 |
p. 23-30
8 p.
|
artikel
|
| 82 |
Prevalence of hyperfibrinolysis in patients with liver cirrhosis
|
Ferro, D.
|
|
1993
|
|
1 |
p. 59-62
4 p.
|
artikel
|
| 83 |
Progress in transfusion medicine
|
Finney, R.D.
|
|
1989
|
|
1 |
p. 55-
1 p.
|
artikel
|
| 84 |
Prolonged very low calorie diet in obese subjects reduces factor VII and PAI but not fibrinogen levels
|
Palareti, G.
|
|
1994
|
|
1 |
p. 16-21
6 p.
|
artikel
|
| 85 |
Proteinases from the fibrinolytic and coagulation systems: Analyses of binding to pregnancy zone protein, a pregnancy-associated plasma proteinase inhibitor
|
Arbelaez, L.F.
|
|
1995
|
|
1 |
p. 41-47
7 p.
|
artikel
|
| 86 |
Recent literature on fibrinolysis
|
|
|
1995
|
|
1 |
p. B1-B3
nvt p.
|
artikel
|
| 87 |
Recent literature on fibrinolysis
|
|
|
1993
|
|
1 |
p. B13-B14
nvt p.
|
artikel
|
| 88 |
Recent literature on fibrinolysis
|
|
|
1992
|
|
1 |
p. B1-B2
nvt p.
|
artikel
|
| 89 |
Recent literature on fibrinolysis
|
|
|
1994
|
|
1 |
p. B1-B2
nvt p.
|
artikel
|
| 90 |
Recent literature on fibrinolysis
|
|
|
1991
|
|
1 |
p. B1-B2
nvt p.
|
artikel
|
| 91 |
Reduction of elevated plasminogen activator inhibitor levels during modest weight loss
|
Sundell, I.B.
|
|
1989
|
|
1 |
p. 51-53
3 p.
|
artikel
|
| 92 |
Relationship between alcohol intake and tissue plasminogen activator antigen and other haemostatic factors in the general population
|
Lee, A.J.
|
|
1995
|
|
1 |
p. 49-54
6 p.
|
artikel
|
| 93 |
Science, man and meaning opening lecture at the 8th International Congress on Fibrinolysis
|
Frankl, V.E.
|
|
1987
|
|
1 |
p. 13-16
4 p.
|
artikel
|
| 94 |
Studies on the interaction between plasminogen activator inhibitor-1 and vitronectin
|
Sigurdardottir, O.
|
|
1992
|
|
1 |
p. 27-32
6 p.
|
artikel
|
| 95 |
Successful recanalisation of experimentally occluded coronary arteries in anaesthetised dogs with recombinant single-chain tissue-type Plasminogen activator (set-PA)
|
Baldus, B.
|
|
1987
|
|
1 |
p. 23-28
6 p.
|
artikel
|
| 96 |
The action of polyanionic agents defibrotide and pentosan sulphate on fibrinolytic activity in the laboratory rat
|
Jamieson, A.
|
|
1996
|
|
1 |
p. 27-35
9 p.
|
artikel
|
| 97 |
The effect of exogenous nitric oxide on plasminogen activator inhibitor in experimentally induced endotoxemia
|
Noci, M.V.
|
|
1996
|
|
1 |
p. 21-25
5 p.
|
artikel
|
| 98 |
The effect of stanozolol on various types of defective fibrinolysis
|
Tengborn, L.
|
|
1987
|
|
1 |
p. 29-32
4 p.
|
artikel
|
| 99 |
The impact of coronary thrombolysis on myocardial infarction
|
Tiefenbrunn, A.J.
|
|
1989
|
|
1 |
p. 1-15
15 p.
|
artikel
|
| 100 |
The risk of thrombosis in hereditary protein S deficiency in a Scandinavian family
|
Jespersen, J.
|
|
1989
|
|
1 |
p. 37-40
4 p.
|
artikel
|
| 101 |
The role of carbohydrate in the activation of plasminogen 2 glycoforms by streptokinase
|
Pirie-Shepherd, S.R.
|
|
1996
|
|
1 |
p. 49-53
5 p.
|
artikel
|
| 102 |
The role of 152Val of the fibrinogen Aα-chain in the fibrin-induced rate enhancement of the plasminogen activation by t-PA
|
Schielen, W.J.G.
|
|
1993
|
|
1 |
p. 63-67
5 p.
|
artikel
|
| 103 |
Thrombolysis and myocardial infarction
|
Tiefenbrunn, A.J.
|
|
1991
|
|
1 |
p. 1-15
15 p.
|
artikel
|
| 104 |
Thrombolytic properties of tissue plasminogen activator (t-PA) and single chain urokinase plasminogen activator (scu-PA) in vitro: Absence of synergy as demonstrated by two quantitative analytical methods
|
Nguyen, G.
|
|
1989
|
|
1 |
p. 23-26
4 p.
|
artikel
|
| 105 |
Tissue plasminogen activator mutants lacking the growth factor domain and the first kringle domain: I
|
Pohl, G.
|
|
1991
|
|
1 |
p. 17-29
13 p.
|
artikel
|
| 106 |
Tissue plasminogen activator mutants lacking the growth factor domain and the first kringle domain: II
|
Wikström, K.
|
|
1991
|
|
1 |
p. 31-41
11 p.
|
artikel
|
| 107 |
Tissue plasminogen activator production from cells cultured in milk extract
|
Electricwala, A.
|
|
1992
|
|
1 |
p. 51-55
5 p.
|
artikel
|
| 108 |
tPA inhibitor, tPA:Ag, plasminogen, and α 2-antiplasmin after low molecular weight heparin or standard heparin
|
Neerstrand, H.
|
|
1987
|
|
1 |
p. 39-43
5 p.
|
artikel
|
| 109 |
Treatment of deep vein thrombosis with a very low molecular weight heparin (CY 222 - Choay): Thrombolysis and plasma fibrinolytic parameters
|
Juhan-Vague, I.
|
|
1988
|
|
1 |
p. 25-29
5 p.
|
artikel
|
| 110 |
Tumour necrosis factor α stimulates the production of pro-urokinase from the A549 lung carcinoma cell line
|
Dosne, A.M.
|
|
1990
|
|
1 |
p. 61-66
6 p.
|
artikel
|
| 111 |
Urokinase and its complex with plasminogen activator inhibitor-3/protein C inhibitor in urine
|
de Munk, G.A.W.
|
|
1994
|
|
1 |
p. 9-15
7 p.
|
artikel
|
| 112 |
Venous occlusion test: Assessment of fibrinolytic capacity by D-dimer latex agglutination test
|
Syrjälä, M.T.
|
|
1993
|
|
1 |
p. 41-45
5 p.
|
artikel
|
Tijdschrift beschrijving